XML 56 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration Agreements, In-Licensing Arrangements And Business Development Activities - In-Licensing Collaborations (Details)
$ in Millions
6 Months Ended
Jul. 02, 2021
USD ($)
Asset Acquisition [Line Items]  
Upfront payment $ 17.0
Collaborative arrangement, maximum aggregate development milestone payments 58.5
Collaborative arrangement, maximum aggregate regulatory milestone payments 139.0
Collaborative arrangement, maximum aggregate commercial milestone payments 377.5
Collaborative Agreement With GamaMabs Pharma SA  
Asset Acquisition [Line Items]  
Payments to acquire assets 5.0
Payment upon closing of transaction 9.0
Asset acquisition, maximum aggregate development milestone payments 42.0
Asset acquisition, maximum aggregate regulatory milestone payments $ 22.5